Sativex multiple sclerosis drug. Patient holding a Sativex spray. This cannabinoid oromucosal mouth spray was developed by GW Pharmaceuticals for mult

---

Sativex multiple sclerosis drug. Patient holding a Sativex spray. This cannabinoid oromucosal mouth spray was developed by GW Pharmaceuticals for multiple sclerosis patients. It is used to alleviate neuropathic pain, spasticity, overactive bladder, and other symptoms. It is also being trialled as a pain control drug for cancer patients.

---

Size: 3413px × 5144px
Photo credit: © MARK THOMAS/SCIENCE PHOTO LIBRARY / Alamy / Afripics
License: Licensed
Model Released: No

Keywords: adult, analgesic, caucasian, close-, detail, device, drug, gw, holding, human, male, man, medical, medicine, mouth, ms, multiple, nabiximols, oromucosal, pain, people, person, pharmaceuticals, pharmacological, pharmacology, prescribed, prescription, relief, sativex, sclerosis, spray, treatment, white